Insmed Inc (NASDAQ:INSM)
| 22.60 Delayed Data As of Jan 18 |  -1.09 / -4.59%Today’s Change | 22.00 Today|||52-Week Range 45.44 | -17.03% Year-to-Date |
Latest INSM News | Press Releases
No recent news for Insmed Inc.
Today’s Trading
| Previous close | 23.73 |
| Today’s open | 23.42 |
| Day’s range | 22.59 - 23.58 |
| Volume | 1,010,758 |
| Average volume (3 months) | 792,173 |
| Market cap | $2.8B |
Data as of 4:01pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | -0.18% |
| Earnings growth (this year) | -26.86% |
| Earnings growth (next 5 years) | +7.60% |
| Revenue growth (last year) | +20.48% |
| P/E ratio | NM |
| Price/Sales | 19.76 |
| Price/Book | 8.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYTKCytokinetics Inc | -0.62 | -1.88% |
| PCRXPacira Biosciences I... | -0.20 | -0.31% |
| FOLDAmicus Therapeutics ... | -1.08 | -10.26% |
| PBHPrestige Consumer He... | -1.32 | -2.21% |
Data as of 4:01pm ET, 01/18/2022
Financials
| Next reporting date | February 24, 2022 |
| EPS forecast (this quarter) | -$0.90 |
| Annual revenue (last year) | $164.4M |
| Annual profit (last year) | -$294.1M |
| Net profit margin | -178.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
